Residual ploidy abnormalities after preimplantation genetic testing for aneuploidy
Zygote · 09.11.2026 · 1-4
DOI: 10.1017/s0967199426100665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zygote, online erschienen am 09.11.2026. Verfasst von Shota Hatakeyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) is widely used for embryo selection, but conventional copy number–based analysis may fail to detect whole-genome ploidy abnormalities such as haploidy and triploidy. This retrospective study evaluated the frequency of residual ploidy abnormalities detected by single-nucleotide polymorphism (SNP)-based analysis among embryos reported as euploid or mosaic by NGS-based PGT-A. Between May 2022 and January 2025, 5983 blastocysts underwent NGS-based PGT-A at Sugiyama Clinic. Of these, 1601 embryos reported as euploid or mosaic were subjected to additional SNP-based ploidy analysis. SNP-based results were classified as diploid, haploid, triploid, or uncertain. Among the 1601 embryos analysed, 1550 (96.8%) were classified as diploid, 4 (0.3%) as haploid, 11 (0.7%) as triploid and 36 (2.2%) as uncertain. The overall frequency of whole-genome ploidy abnormalities was 0.9% (15/1601). Among the 11 triploid embryos, 4 were derived from intracytoplasmic sperm injection (ICSI) and 7 from conventional in vitro fertilization. All haploid and triploid embryos derived from ICSI showed second polar body extrusion on retrospective time-lapse review. These findings indicate that a small but measurable proportion of embryos reported as euploid or mosaic by NGS-based PGT-A have whole-genome ploidy abnormalities detectable by SNP-based analysis. SNP-based ploidy assessment may provide complementary information in selected clinical workflows.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan.
ORCID-Profile: Shota Hatakeyama
Zitieren
APA
Hatakeyama, S., Shirai, A., Yamashiro, E., Watanabe, H., Tabata, S., Morita, E., Takeda, S., Asano, S., Yamamoto, K., Ueno, S., Nakagawa, K., & Sugiyama, R. (2026). Residual ploidy abnormalities after preimplantation genetic testing for aneuploidy. Zygote, 1-4. https://doi.org/10.1017/s0967199426100665
Vancouver
Hatakeyama S, Shirai A, Yamashiro E, Watanabe H, Tabata S, Morita E, et al. Residual ploidy abnormalities after preimplantation genetic testing for aneuploidy. Zygote. 2026:1-4. doi:10.1017/s0967199426100665
BibTeX
@article{Hatakeyama2026,
author = {Hatakeyama, Shota and Shirai, Asako and Yamashiro, Emi and Watanabe, Hideaki and Tabata, Sakura and Morita, Erika and Takeda, Satomi and Asano, Shiori and Yamamoto, Kota and Ueno, Satoshi and Nakagawa, Koji and Sugiyama, Rikikazu},
title = {Residual ploidy abnormalities after preimplantation genetic testing for aneuploidy},
journal = {Zygote},
year = {2026},
pages = {1--4},
doi = {10.1017/s0967199426100665}
}
EUVIMED